Carregant...
Predicting treatment response to IL6R blockers in rheumatoid arthritis
Patients with severe, active RA who have not responded to conventional therapy may receive biological disease modifying anti-rheumatic drugs (bDMARDs). However, 40% of cases do not achieve complete disease control, resulting in a negative impact on patient quality of life and representing a waste of...
Guardat en:
| Publicat a: | Rheumatology (Oxford) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733712/ https://ncbi.nlm.nih.gov/pubmed/32864695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa529 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|